MGX · Metagenomi Therapeutics, Inc.
Market Cap
$44.95M
Shares
37.78M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
Key facts
CIK
1785279
CUSIP
59102M104
13F (30d)
40 filings
40 filers
Visit website
Investor relations